WallStreetZenWallStreetZen

NASDAQ: AFIB
Acutus Medical Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their AFIB stock forecasts and price targets.

Forecast return on equity

Is AFIB forecast to generate an efficient return?

Forecast return on assets

Is AFIB forecast to generate an efficient return on assets?

AFIB vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AFIB$0.17N/AN/A
BIOL$0.15$2.20+1,366.67%Buy
THMO$0.65$5.00+669.23%Buy
XYLO$2.51N/AN/A
VERO$0.84N/AN/A

Acutus Medical Stock Forecast FAQ

What is AFIB's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: AFIB) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Acutus Medical stock.

What is AFIB's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: AFIB) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 9.14%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.